20250161421. Co-vaccination Cd4 (CECAVA & . KG)
CO-VACCINATION WITH CD4 AND CD8 ANTIGENS
Abstract: the present invention relates to a vaccine composition comprising a first peptide being an mhc i antigen and a second peptide being an mhc ii antigen, wherein the sequence of the first peptide is comprised in the sequence of the second peptide. the present invention further relates to a kit of parts comprising the same. instant compositions and kits are particularly useful in the methods of inducing or increasing an immune response in a subject. instant compositions are further useful in the methods of treatment or prevention of a disease or a disorder in a subject, in particular an infectious disease or a cancer disease.
Inventor(s): Henning Zelba, Saskia Biskup, Dirk Hadaschik, Oliver Bartsch, Magdalena Feldhahn, Christina Kyzirakos-Feger, Simone Kayser
CPC Classification: A61K39/001114 (Medicinal preparations containing antigens or antibodies (materials for immunoassay ))
Search for rejections for patent application number 20250161421